Hedvika Lazar

972 total citations
18 papers, 768 citations indexed

About

Hedvika Lazar is a scholar working on Epidemiology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Hedvika Lazar has authored 18 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Molecular Medicine and 4 papers in Molecular Biology. Recurrent topics in Hedvika Lazar's work include Pneumonia and Respiratory Infections (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Influenza Virus Research Studies (4 papers). Hedvika Lazar is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Influenza Virus Research Studies (4 papers). Hedvika Lazar collaborates with scholars based in Switzerland, France and Belgium. Hedvika Lazar's co-authors include Christian Herzog, Oliver Kürsteiner, Reinhard Glück, Robert Mischler, Katharina Hartmann, Rolf Jaggi, Andreas Marti, Peter Durrer, Michael P. Rudolf and Michael P. Horn and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Hedvika Lazar

17 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hedvika Lazar Switzerland 13 260 252 202 151 148 18 768
Zachary Cusumano United States 13 349 1.3× 190 0.8× 93 0.5× 98 0.6× 94 0.6× 21 782
Hongxia Niu China 18 329 1.3× 241 1.0× 258 1.3× 116 0.8× 381 2.6× 38 840
Vivekananda Datta United States 15 350 1.3× 159 0.6× 246 1.2× 118 0.8× 530 3.6× 21 1.5k
Minako Araake Japan 14 249 1.0× 154 0.6× 215 1.1× 164 1.1× 228 1.5× 48 818
Wenjia Sun China 18 397 1.5× 215 0.9× 227 1.1× 244 1.6× 125 0.8× 39 973
María Gómez Italy 21 351 1.4× 386 1.5× 296 1.5× 72 0.5× 427 2.9× 42 1.1k
Jessica Bonnell United States 11 309 1.2× 120 0.5× 128 0.6× 256 1.7× 115 0.8× 13 714
Amapola Manrique Switzerland 11 224 0.9× 210 0.8× 398 2.0× 114 0.8× 323 2.2× 17 1.0k
Seyed Fazlollah Mousavi Iran 14 238 0.9× 215 0.9× 141 0.7× 53 0.4× 141 1.0× 48 612
Richard K. Groger United States 14 247 0.9× 443 1.8× 132 0.7× 44 0.3× 320 2.2× 18 839

Countries citing papers authored by Hedvika Lazar

Since Specialization
Citations

This map shows the geographic impact of Hedvika Lazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hedvika Lazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hedvika Lazar more than expected).

Fields of papers citing papers by Hedvika Lazar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hedvika Lazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hedvika Lazar. The network helps show where Hedvika Lazar may publish in the future.

Co-authorship network of co-authors of Hedvika Lazar

This figure shows the co-authorship network connecting the top 25 collaborators of Hedvika Lazar. A scholar is included among the top collaborators of Hedvika Lazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hedvika Lazar. Hedvika Lazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Al‐Samkari, Hanny, Antoni Riera‐Mestre, Sophie Dupuis‐Girod, et al.. (2025). Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia. New England Journal of Medicine. 393(21). 2131–2141.
2.
3.
Lü, Qin, Philippe Eggimann, Charles‐Édouard Luyt, et al.. (2014). Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes. Critical Care. 18(1). R17–R17. 64 indexed citations
4.
Que, Yok‐Ai, Hedvika Lazar, Michel Wolff, et al.. (2014). Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 33(10). 1861–1867. 55 indexed citations
5.
6.
Lü, Qin, Jean‐Jacques Rouby, Philippe Eggimann, et al.. (2011). Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia. Journal of Antimicrobial Chemotherapy. 66(5). 1110–1116. 52 indexed citations
7.
Horn, Michael P., Adrian W. Zuercher, Martin A. Imboden, et al.. (2010). PreclinicalIn VitroandIn VivoCharacterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific forPseudomonas aeruginosaSerotype IATS-O11. Antimicrobial Agents and Chemotherapy. 54(6). 2338–2344. 47 indexed citations
8.
Herzog, Christian, Katharina Hartmann, Oliver Kürsteiner, et al.. (2009). Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine. Vaccine. 27(33). 4381–4387. 215 indexed citations
9.
Lazar, Hedvika, Michael P. Horn, Adrian W. Zuercher, et al.. (2009). Pharmacokinetics and Safety Profile of the Human Anti- Pseudomonas aeruginosa Serotype O11 Immunoglobulin M Monoclonal Antibody KBPA-101 in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 53(8). 3442–3446. 43 indexed citations
10.
Kürsteiner, Oliver, Christian Moser, Hedvika Lazar, & Peter Durrer. (2006). Inflexal® V—The influenza vaccine with the lowest ovalbumin content. Vaccine. 24(44-46). 6632–6635. 24 indexed citations
11.
Kanra, G, Paola Marchisio, Cornelia Feiterna‐Sperling, et al.. (2004). Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. The Pediatric Infectious Disease Journal. 23(4). 300–306. 66 indexed citations
12.
Frech, Sarah A., Richard T. Kenney, Hedvika Lazar, et al.. (2004). Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine. 23(7). 946–950. 68 indexed citations
13.
Marti, Andreas, H.U. Graber, Hedvika Lazar, et al.. (2002). Caspases: Decoders of Apoptotic Signals During Mammary Involution. Advances in experimental medicine and biology. 480. 195–201. 15 indexed citations
14.
Marti, Andreas, Richard Jäger, Hedvika Lazar, et al.. (2001). Mouse mammary gland involution is associated with cytochrome c release and caspase activation. Mechanisms of Development. 104(1-2). 89–98. 30 indexed citations
15.
Lazar, Hedvika, et al.. (2000). Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis. International Journal of Cancer. 85(4). 578–578. 1 indexed citations
16.
Lazar, Hedvika, Anna Baltzer, Claude Gimmi, Andreas Marti, & Rolf Jaggi. (2000). Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis. International Journal of Cancer. 85(4). 578–583. 14 indexed citations
17.
Marti, Andreas, et al.. (1999). Transcription Factor Activities and Gene Expression During Mouse Mammary Gland Involution. Journal of Mammary Gland Biology and Neoplasia. 4(2). 145–152. 59 indexed citations
18.
Lazar, Hedvika, et al.. (1959). FURTHER OBSERVATIONS ON THE MECHANISM OF ULCER PAIN. Annals of Internal Medicine. 51(6). 1275–1294. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zachary Cusumano Breakdown of academic impact, for papers by Hongxia Niu Breakdown of academic impact, for papers by Vivekananda Datta Breakdown of academic impact, for papers by Minako Araake Breakdown of academic impact, for papers by Wenjia Sun Breakdown of academic impact, for papers by María Gómez Breakdown of academic impact, for papers by Jessica Bonnell Breakdown of academic impact, for papers by Amapola Manrique Breakdown of academic impact, for papers by Seyed Fazlollah Mousavi Breakdown of academic impact, for papers by Richard K. Groger
Rankless by CCL
2026